Cited by 60Amino Acid Enzymes and MetabolismCancer Research and TreatmentsBiochemical and Molecular Research

Glutamine antagonists in chemotherapy

Livingston, R.B., Venditti, J.M., Cooney, D.A., Carter, S.K.·1971·Advances in Pharmacology

Integrity signals

Registry

Crossref · 10.1016/s1054-3589(08)60594-3

Cites

75 of 75 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Clinical trials using glutamine analogues were abandoned due to lack of efficacy and/or severe toxicity, likely because the drugs were relatively non-specific and affected many glutamine-utilizing enzymes.

    “Clinical trials using glutamine analogues to treat cancers were initiated decades ago, but these trials were abandoned due to lack of efficacy and/or severe patient toxicity (Livingston et al., 1970; O’Dwyer et al., 1984). The absence of a therapeutic window for these studies can likely be attributed to fact that these drugs were relatively non-specific and a panoply of glutamine utilizing enzymes”

    From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Livingston et al., 1970

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Livingston, R. B., Venditti, J. M., Cooney, D. A., & Carter, S. K.
Affiliations
National Institutes of Health (US)
Venue
Advances in Pharmacology
Publisher
Elsevier
Published
1971
Volume
8
Pages
57-120
ISSN
1054-3589 (ISSN-L)
OpenAlex
W1438529674
Cited by
60
References
75
Citations by year
2026: 1 · 2025: 4 · 2024: 1 · 2023: 4 · 2022: 2 · 2020: 2 · 2019: 1 · 2018: 3 · 2017: 2 · 2016: 1 · 2014: 1 · 2013: 2
FWCI
2.36
Type
book chapter
Language
en
Open access
closed
Locations
  • Advances in pharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Cancer Research and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
Keywords
glutamine antagonist, L-asparaginase, azaserine, glutaminase, combination chemotherapy, anticancer agents, Escherichia coli asparaginase
MeSH terms
Adult, Aminobutyrates, Animals, Asparaginase, Azaserine, Azo Compounds, Child, Diazooxonorleucine, Drug Combinations, Drug Interactions, Glutaminase, Glutamine, Glutamate-Ammonia Ligase, Humans, Hydroxylysine, Leukemia, Leukemia L1210, Liver, Methionine Sulfoximine, Neoplasms, RNA, Transfer, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review